• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Wellin5 Acquires Mental Health Journaling and Tracking App Therachat

Share:

February 12, 2020

Highlights on this story:
  • Wellin5 acquires Therachat, a HIPAA-compliant smart journaling tool that keeps clients engaged in-between therapy sessions for an undisclosed term.
  • The acquisition supports Wellin5’s long-term strategy of expansion into the United States telehatlh market.

Wellin5, an innovative online telehealth counseling platform, today announced its acquisition of Therachat, a San Francisco, CA-based mental health platform designed to help therapists, psychologists, and mental health counselors in the US to keep their patients engaged in between therapy sessions. The acquisition is part of its long-term expansion strategy that began in September 2019 when it named Sacramento, California its US Headquarters.

Secure App To Improve Your Mental Health

Recent data from the National Alliance on Mental Illness (NAMI) found that one in five adults in the U.S. (43.8 million people) suffer from mental illness each year. With a widespread need for accessible mental health services, technology offers new options for people looking to cope with mild to severe symptoms.

Founded in 2016, Therachat is a HIPAA-compliant smart journaling tool available on iOS and Android devices that keeps clients engaged in-between therapy sessions. Therachat’s mobile app for therapy clients and users without a therapist is powered by AI technology that helps to cope with anxiety. Its web-based dashboard provides therapists with over 40 premade and customizable homework activities with real-time insights to improve therapy outcomes.

Therachat Acquisition Benefits for Wellin5

Wellin5’s counseling platform uses AI-powered technology and smart-logic driven software to combat mental health challenges by quickly connecting its users with the most compatible counselor. As a leader in online counseling, Wellin5 provides captivating user experience and highly engaging service, in turn, creating a new understanding of mental wellness.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The acquisition of Therachat positions Wellin5 to expand its mental health expertise to include:

– Offering a full client and counselor centric experience on a centralized platform

– A library of mobile health tools such as emotion tracking, thought reframing, mindfulness, etc.

– Meaningful support through engagement and self-help mental health exercises

– An additional 5,000 therapists to add to its existing base of mental health professionals.

“We are very excited about acquiring Therachat,” stated William Masih, Founder, and CEO of Wellin5. “This is a massive accomplishment in our plan to emerge as a leader in the preventive mental health space. Wellin5 is strongly positioned to grow exponentially over the next three to five years in North America and internationally. This year, we expect to close the next round of funding to expand our partnerships with insurance providers and employee benefits administrators to support our anticipated growth model.” Financial details of the acquisition were not disclosed

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Disruptive Technologies and Emerging Trends Drive Life Science TransformationDisruptive Technologies and Emerging Trends Drive Life Science Transformation
  • Healthcare PE Firm Heritage Group Launches $300M Health Tech FundHealthcare PE Firm Heritage Group Launches $300M Health Tech Fund
  • PointClickcare Acquires Value-Based Care EHR Patient PatternPointClickcare Acquires Value-Based Care EHR Patient Pattern
  • PharmaDrug CEO Provides Vision for Securedose AcquisitionPharmaDrug CEO Provides Vision for Securedose Acquisition
  • Nestlé Snaps Up Outstanding Shares of Aimmune for $2.6 BillionNestlé Snaps Up Outstanding Shares of Aimmune for $2.6 Billion
  • Seven Ways Blockchain Will Change Your Health Care ExperienceSeven Ways Blockchain Will Change Your Health Care Experience
  • By Embracing Biomarkers, ‘Empathetic Technology’ Can Address Health Issues Unbeknownst To Its UsersBy Embracing Biomarkers, ‘Empathetic Technology’ Can Address Health Issues Unbeknownst To Its Users
  • Why Alexion Makes Sense As A Target, But Amgen Doesn’t As A BuyerWhy Alexion Makes Sense As A Target, But Amgen Doesn’t As A Buyer

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications